Jun Sato

11PUBLICATIONS

54CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 18, 2026

Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.

|Jan 20, 2025

A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors.

Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama

|Aug 14, 2024

Phase I Study of Simlukafusp Alfa (FAP-IL2v) with or without Atezolizumab in Japanese Patients with Advanced Solid Tumors.

Takafumi Koyama, Kan Yonemori, Toshio Shimizu

|Nov 02, 2023

Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.

Tomoyuki Satake, Shunsuke Kondo, Noriko Tanabe

|Jul 12, 2023

Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.

Hanae Ida, Toshio Shimizu, Makoto Nishino

|Sep 09, 2022

First-in-human study of ONO-4578, an antagonist of prostaglandin E<sub>2</sub> receptor 4, alone and with nivolumab in solid tumors.

Satoru Iwasa, Takafumi Koyama, Makoto Nishino

Pageof 2

Frequent Collaborators

10 joint publications

Noboru Yamamoto

Takafumi Koyama

Kan Yonemori

Yuki Katsuya

Shunsuke Kondo

Yutaka Fujiwara

Kazuki Sudo

Shigehisa Kitano

Toshio Shimizu

Akihiko Shimomura

Frequent Collaborators

10 joint publications

Noboru Yamamoto

9 joint publications

Takafumi Koyama

7 joint publications

Kan Yonemori

5 joint publications

Yuki Katsuya